The China Mail - US researchers seek to legitimize AI mental health care

USD -
AED 3.672496
AFN 68.18705
ALL 82.654845
AMD 382.36924
ANG 1.790403
AOA 916.99971
ARS 1451.445104
AUD 1.504019
AWG 1.8
AZN 1.707273
BAM 1.66742
BBD 2.014834
BDT 121.74432
BGN 1.666425
BHD 0.377083
BIF 2985.464001
BMD 1
BND 1.283345
BOB 6.912486
BRL 5.353103
BSD 1.000384
BTN 88.242466
BWP 13.326229
BYN 3.38838
BYR 19600
BZD 2.011936
CAD 1.384195
CDF 2835.00015
CHF 0.796785
CLF 0.02426
CLP 951.728548
CNY 7.124701
CNH 7.12354
COP 3893.772113
CRC 503.94305
CUC 1
CUP 26.5
CVE 94.006565
CZK 20.74715
DJF 178.140586
DKK 6.36682
DOP 63.421288
DZD 129.420691
EGP 48.067104
ERN 15
ETB 143.637069
EUR 0.852961
FJD 2.238696
FKP 0.737679
GBP 0.737905
GEL 2.689777
GGP 0.737679
GHS 12.204271
GIP 0.737679
GMD 71.500902
GNF 8676.414169
GTQ 7.669551
GYD 209.292809
HKD 7.779923
HNL 26.209131
HRK 6.425297
HTG 130.90072
HUF 332.879926
IDR 16408
ILS 3.335965
IMP 0.737679
INR 88.277501
IQD 1310.541796
IRR 42075.000562
ISK 122.030058
JEP 0.737679
JMD 160.475724
JOD 0.709006
JPY 147.662503
KES 129.249972
KGS 87.449795
KHR 4009.548574
KMF 419.506512
KPW 900.03427
KRW 1392.339996
KWD 0.30537
KYD 0.83371
KZT 540.935249
LAK 21691.461699
LBP 89584.381261
LKR 301.837248
LRD 177.569376
LSL 17.362036
LTL 2.95274
LVL 0.60489
LYD 5.401765
MAD 9.008824
MDL 16.616224
MGA 4433.26655
MKD 52.466005
MMK 2099.833626
MNT 3596.020755
MOP 8.019268
MRU 39.935206
MUR 45.479981
MVR 15.310197
MWK 1734.600793
MXN 18.45195
MYR 4.204976
MZN 63.910518
NAD 17.362036
NGN 1500.850375
NIO 36.813163
NOK 9.86678
NPR 141.187604
NZD 1.679699
OMR 0.383563
PAB 1.000384
PEN 3.486338
PGK 4.239737
PHP 57.207001
PKR 284.023957
PLN 3.629555
PYG 7148.642312
QAR 3.651903
RON 4.317099
RSD 99.867855
RUB 83.397664
RWF 1449.592907
SAR 3.750597
SBD 8.206879
SCR 14.26498
SDG 601.502513
SEK 9.331397
SGD 1.282535
SHP 0.785843
SLE 23.37501
SLL 20969.503664
SOS 571.720875
SRD 39.375022
STD 20697.981008
STN 20.887506
SVC 8.753144
SYP 13001.951397
SZL 17.345155
THB 31.749595
TJS 9.413615
TMT 3.51
TND 2.912145
TOP 2.3421
TRY 41.336799
TTD 6.801654
TWD 30.299901
TZS 2460.974466
UAH 41.241911
UGX 3515.921395
UYU 40.069909
UZS 12452.363698
VES 158.73035
VND 26385
VUV 118.929522
WST 2.747698
XAF 559.236967
XAG 0.023712
XAU 0.000275
XCD 2.70255
XCG 1.802975
XDR 0.695511
XOF 559.236967
XPF 101.675263
YER 239.550483
ZAR 17.359398
ZMK 9001.202571
ZMW 23.734175
ZWL 321.999592
  • RBGPF

    0.0000

    77.27

    0%

  • NGG

    0.5300

    71.6

    +0.74%

  • BTI

    -0.7200

    56.59

    -1.27%

  • VOD

    -0.0100

    11.85

    -0.08%

  • RYCEF

    0.1800

    15.37

    +1.17%

  • RELX

    0.1700

    46.5

    +0.37%

  • CMSC

    -0.0200

    24.36

    -0.08%

  • GSK

    -0.6500

    40.83

    -1.59%

  • BP

    -0.5800

    33.89

    -1.71%

  • SCS

    -0.1900

    16.81

    -1.13%

  • RIO

    -0.1000

    62.44

    -0.16%

  • CMSD

    0.0100

    24.4

    +0.04%

  • AZN

    -1.5400

    79.56

    -1.94%

  • BCC

    -3.3300

    85.68

    -3.89%

  • JRI

    0.1100

    14.23

    +0.77%

  • BCE

    -0.1400

    24.16

    -0.58%

US researchers seek to legitimize AI mental health care
US researchers seek to legitimize AI mental health care / Photo: © GETTY IMAGES NORTH AMERICA/AFP/File

US researchers seek to legitimize AI mental health care

Researchers at Dartmouth College believe artificial intelligence can deliver reliable psychotherapy, distinguishing their work from the unproven and sometimes dubious mental health apps flooding today's market.

Text size:

Their application, Therabot, addresses the critical shortage of mental health professionals.

According to Nick Jacobson, an assistant professor of data science and psychiatry at Dartmouth, even multiplying the current number of therapists tenfold would leave too few to meet demand.

"We need something different to meet this large need," Jacobson told AFP.

The Dartmouth team recently published a clinical study demonstrating Therabot's effectiveness in helping people with anxiety, depression and eating disorders.

A new trial is planned to compare Therabot's results with conventional therapies.

The medical establishment appears receptive to such innovation.

Vaile Wright, senior director of health care innovation at the American Psychological Association (APA), described "a future where you will have an AI-generated chatbot rooted in science that is co-created by experts and developed for the purpose of addressing mental health."

Wright noted these applications "have a lot of promise, particularly if they are done responsibly and ethically," though she expressed concerns about potential harm to younger users.

Jacobson's team has so far dedicated close to six years to developing Therabot, with safety and effectiveness as primary goals.

Michael Heinz, psychiatrist and project co-leader, believes rushing for profit would compromise safety.

The Dartmouth team is prioritizing understanding how their digital therapist works and establishing trust.

They are also contemplating the creation of a nonprofit entity linked to Therabot to make digital therapy accessible to those who cannot afford conventional in-person help.

- Care or cash? -

With the cautious approach of its developers, Therabot could potentially be a standout in a marketplace of untested apps that claim to address loneliness, sadness and other issues.

According to Wright, many apps appear designed more to capture attention and generate revenue than improve mental health.

Such models keep people engaged by telling them what they want to hear, but young users often lack the savvy to realize they are being manipulated.

Darlene King, chair of the American Psychiatric Association's committee on mental health technology, acknowledged AI's potential for addressing mental health challenges but emphasizes the need for more information before determining true benefits and risks.

"There are still a lot of questions," King noted.

To minimize unexpected outcomes, the Therabot team went beyond mining therapy transcripts and training videos to fuel its AI app by manually creating simulated patient-caregiver conversations.

While the US Food and Drug Administration theoretically is responsible for regulating online mental health treatment, it does not certify medical devices or AI apps.

Instead, "the FDA may authorize their marketing after reviewing the appropriate pre-market submission," according to an agency spokesperson.

The FDA acknowledged that "digital mental health therapies have the potential to improve patient access to behavioral therapies."

- Therapist always in -

Herbert Bay, CEO of Earkick, defends his startup's AI therapist Panda as "super safe."

Bay says Earkick is conducting a clinical study of its digital therapist, which detects emotional crisis signs or suicidal ideation and sends help alerts.

"What happened with Character.AI couldn't happen with us," said Bay, referring to a Florida case in which a mother claims a chatbot relationship contributed to her 14-year-old son's death by suicide.

AI, for now, is suited more for day-to-day mental health support than life-shaking breakdowns, according to Bay.

"Calling your therapist at two in the morning is just not possible," but a therapy chatbot remains always available, Bay noted.

One user named Darren, who declined to provide his last name, found ChatGPT helpful in managing his traumatic stress disorder, despite the OpenAI assistant not being designed specifically for mental health.

"I feel like it's working for me," he said.

"I would recommend it to people who suffer from anxiety and are in distress."

K.Lam--ThChM